文献速递心脑血管急症重症综合管理与镇静镇痛

急诊科就诊的脑静脉血栓形成患者的临床流行病学特征与结局

Clinico-epidemiological profile & outcome of patients presenting with cerebral venous thrombosis to emergency department.
PubMed 文献 · Am J Emerg Med · 2024-09-02
一句话结论脑静脉血栓形成患者中男性、酒精中毒和贫血常见,入院和住院期间需气管插管者多,院内死亡17.9%、六周随访升至22.4%;低GCS和需高级干预是预后不良的关键决定因素。

这项在印度南部三级教学医院开展的前瞻性观察研究纳入140例≥18岁脑静脉血栓形成(CVT)患者,中位年龄34岁,61.4%为男性。最常见症状为头痛(70.7%),最常见体征为视乳头水肿(60.7%);非增强CT最常见表现为出血性梗死(39.4%),最常累及上矢状窦;最常见危险因素为酒精中毒(45%)、贫血(27.1%)、吸烟(21.4%)、口服避孕药(12.1%)和高血压(12.1%)。6.4%患者就诊时需气管插管、22.9%住院期间需插管,院内死亡率17.9%,六周随访升至22.4%,出院时预后良好者57.9%、六周升至69.4%。作者强调识别CVT核心症状和包括酒精中毒、贫血在内的多种危险因素,低GCS评分和需高级干预是发病和死亡的关键决定因素。

要点

  • 140例CVT患者中位年龄34岁、61.4%为男性,头痛(70.7%)和视乳头水肿(60.7%)是最常见症状和体征。
  • 非增强CT最常见为出血性梗死(39.4%),最常累及上矢状窦;酒精中毒(45%)、贫血(27.1%)是最常见危险因素。
  • 6.4%患者就诊时需气管插管、22.9%住院期间需插管,平均住院13.9天,提示部分CVT患者气道和重症监护需求高。
  • 院内死亡率17.9%、六周随访升至22.4%;出院时mRS 3-5占24.3%、六周降至8.2%,出院时预后良好57.9%、六周升至69.4%。
  • 作者认为低GCS评分和需高级干预是发病和死亡的关键决定因素,多数患者六周随访时神经功能预后良好。

适用人群与场景

  • 印度南部一家三级教学医院急诊科就诊的≥18岁脑静脉血栓形成成人患者,研究期为2020年7月至2022年6月共两年。

红旗征与不能漏的情况

  • 就诊时6.4%患者需气管插管、住院期间22.9%需气管插管,提示部分CVT患者存在需要气道保护和重症监护的严重状态。
  • 作者认为低GCS评分和需高级干预是发病和死亡的关键决定因素。

研究设计与关键结果

  • 前瞻性观察研究,纳入140例CVT患者,中位年龄34岁,61.4%为男性。
  • 最常见症状为头痛(70.7%),最常见体征为视乳头水肿(60.7%);非增强CT最常见为出血性梗死(39.4%),最常累及上矢状窦。
  • 最常见危险因素为酒精中毒(45%)、贫血(27.1%)、吸烟(21.4%)、口服避孕药(12.1%)、高血压(12.1%);深静脉血栓或肺栓塞占5%。
  • 平均住院13.9天,就诊时需气管插管6.4%、住院期间需气管插管22.9%。
  • 院内死亡率17.9%,六周随访升至22.4%;出院时mRS 3-5为24.3%、六周降至8.2%;出院时预后良好57.9%、六周升至69.4%。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为应识别CVT的核心症状和包括酒精中毒、贫血在内的多种危险因素。
  • 作者认为低GCS评分和需高级干预是发病和死亡的关键决定因素;多数患者六周随访时神经功能预后良好。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To better understand the clinical and radiological characteristics of Cerebral Venous Thrombosis (CVT), we conducted a study focusing on the assessment of neurological outcomes and factors associated with poor prognosis in patients with CVT.

METHODS: This prospective, observational study took place over two years (July 2020 to June 2022) in a tertiary care teaching hospital in South India, encompassing adults aged 18 years and over. Key data points included demographic information, symptomatology, physical and neurological examinations, neuroimaging findings, hospital interventions, and neurological outcomes at discharge and at a six-week telephonic follow-up.

RESULTS: A total of 140 patients with CVT, median age 34 years, were studied. 61.4 % were males. The most common symptoms and signs were headaches (70.7 %) and papilledema (60.7 %). Hemorrhagic infarct was the most prevalent finding on the non-contrast computed tomography (NCCT) of the brain, involving 39.4 % of patients. The most commonly affected sinus was the superior sagittal sinus. Risk factors most often observed were alcoholism (45 %), smoking (21.4 %), anemia (27.1 %), oral contraceptive pill usage (12.1 %), and hypertension (12.1 %). Deep vein thrombosis or pulmonary embolism was present in 5 % of the patients. The mean hospital stay was 13.9 days, with 6.4 % of patients requiring endotracheal intubation at presentation and 22.9 % during their stay. The observed in-hospital mortality rate was 17.9 %, increasing to 22.4 % at the six-week follow-up. Morbidity (mRS 3-5) was 24.3 % at discharge, decreasing to 8.2 % at six-week follow-up. Favorable outcomes were reported in 57.9 % of cases at discharge, rising to 69.4 % at six weeks.

CONCLUSIONS: Our study underscores the importance of recognizing cardinal symptoms and diverse risk factors of CVT, including alcoholism and anemia. Majority of CVT occurrences were observed in males aged 18-29. Critical determinants of heightened morbidity and mortality were identified, including lower GCS scores and the necessity for advanced interventions. Notably, majority of patients presented favorable neurological outcomes at six-week follow-up.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Konuri B, Ayyan SM, Vivekanandan M, et al. Clinico-epidemiological profile & outcome of patients presenting with cerebral venous thrombosis to emergency department. Am J Emerg Med. 2024. PMID: 39241293. doi:10.1016/j.ajem.2024.08.034

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。